The global inequity of COVID-19 diagnostics : challenges and opportunities
Abstract
Diagnostics for COVID-19 have advanced at an unprecedented pace over the last two years. Testing is a critical pillar of pandemic control, and is required for epidemiological tracking, treatment, and surveillance. Despite high quality SARS-CoV-2 viral diagnostic capability, there are vast global inequities in access. The Virology, Immunology, and Diagnostics Working Group(WG) of the COVID-19 Clinical Research Coalition (CRC) brings together experts in immunology, infectious diseases, and microbiology to advocate for equity-based COVID-19 research, prioritising solutions driven by communities in low-income and lower middle-income countries (LMICs).1 This commentary shares the unique perspective of the WG on the asymmetry in COVID-19 diagnostic access between low-income and high-income settings, the barriers to these disparities, and highlights opportunities to remedy these inequities.
Citation
Narayanasamy , S , Okware , B , Muttamba , W , Patel , K , Duedu , K O , Ravi , N , Ellermeier , N , Shey , M , Woods , C W , Sabiiti , W & COVID-19 Clinical Research Coalition, Virology, Immunology, and Diagnostics Working Group 2022 , ' The global inequity of COVID-19 diagnostics : challenges and opportunities ' , Journal of Epidemiology and Community Health , vol. 76 , no. 12 , pp. 972-975 . https://doi.org/10.1136/jech-2022-219333
Publication
Journal of Epidemiology and Community Health
Status
Peer reviewed
ISSN
0143-005XType
Journal article
Collections
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.